Genentech licenses SurModics tech for SR Lucentis
Its new microparticle technology licensing deal with Genentech could be worth as much as $200m (€136m) says US delivery specialist SurModics.
Archives for October 6, 2009
MannKind’s shares tumble; deal unlikely in 2009
MannKind’s share price tumbled by 31 per cent yesterday, just days after it published encouraging safety data for Afresa, because it revealed a partnership deal is unlikely to occur in 2009.
CRO biz key to Epistem’s growth in FY 2009
Epistem says its focus on epithelial stem cell services and growth of its CRO and biomarker businesses helped it to stave off the downturn and post a strong set of financials of the fiscal year ended June 30.
GVK & QS partnership offers trial outcome data
Following a “significant increase in demand” GVK Biosciences has partnered with Quantitative Solutions (QS) to develop and market clinical trial outcome databases, which they believe can improve drug development.
GSK forms JV to expand in Chinese vaccine market
GSK and Walvax have entered into a long-term joint venture (JV) to serve the Chinese vaccine market, with the big pharma transferring technology to enable local production and building a manufacturing plant.